182 related articles for article (PubMed ID: 30451730)
1. Accelerated Hypofractionated Radiation Therapy for Elderly Frail Bladder Cancer Patients Unfit for Surgery or Chemotherapy.
Hammer L; Laufer M; Dotan Z; Leibowitz-Amit R; Berger R; Felder S; Weiss I; Lawrence YR; Symon Z
Am J Clin Oncol; 2019 Feb; 42(2):179-183. PubMed ID: 30451730
[TBL] [Abstract][Full Text] [Related]
2. Whole Versus Partial Bladder Radiation: Use of an Image-guided Hypofractionated IMRT Bladder-preservation Protocol.
Kang JJ; Steinberg ML; Kupelian P; Alexander S; King CR
Am J Clin Oncol; 2018 Feb; 41(2):107-114. PubMed ID: 26535994
[TBL] [Abstract][Full Text] [Related]
3. Is Ultra Hypofractionated Radiation Therapy a Safe and Effective Treatment for Invasive Bladder Cancer in the Elderly?: A Retrospective Single Institution Review.
Symon N; Mattout J; Lewin R; Hammer L; Laufer M; Berger R; Leibowitz R; Dotan Z; Ben-Ayun M; Tsvang L; Weiss I; Symon Z
Am J Clin Oncol; 2021 Jul; 44(7):369-373. PubMed ID: 33927135
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated intensity modulated radiation therapy in combined modality treatment for bladder preservation in elderly patients with invasive bladder cancer.
Turgeon GA; Souhami L; Cury FL; Faria SL; Duclos M; Sturgeon J; Kassouf W
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):326-31. PubMed ID: 24411604
[TBL] [Abstract][Full Text] [Related]
5. Promising results with image guided intensity modulated radiotherapy for muscle invasive bladder cancer.
Whalley D; Caine H; McCloud P; Guo L; Kneebone A; Eade T
Radiat Oncol; 2015 Sep; 10():205. PubMed ID: 26407726
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical Treatment.
Hafeez S; McDonald F; Lalondrelle S; McNair H; Warren-Oseni K; Jones K; Harris V; Taylor H; Khoo V; Thomas K; Hansen V; Dearnaley D; Horwich A; Huddart R
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):115-122. PubMed ID: 28586948
[TBL] [Abstract][Full Text] [Related]
7. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.
Zietman AL; Grocela J; Zehr E; Kaufman DS; Young RH; Althausen AF; Heney NM; Shipley WU
Urology; 2001 Sep; 58(3):380-5. PubMed ID: 11549485
[TBL] [Abstract][Full Text] [Related]
8. Curative radiation therapy for very elderly bladder cancer patients with localized disease.
Bonet M; Bonfill T; Nuñez M; De Verdonces L; Mur E; Gallardo E; Fernandez-Morales L; Aguilar A; Prats J; Arenas M
Clin Transl Oncol; 2018 Jul; 20(7):899-905. PubMed ID: 29159793
[TBL] [Abstract][Full Text] [Related]
9. Clinical Outcomes With Dose-Escalated Adaptive Radiation Therapy for Urinary Bladder Cancer: A Prospective Study.
Murthy V; Masodkar R; Kalyani N; Mahantshetty U; Bakshi G; Prakash G; Joshi A; Prabhash K; Ghonge S; Shrivastava S
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):60-66. PubMed ID: 26547385
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of efficacy and toxicity in two different hypofractionated 3D-conformal external beam radiotherapy schedules in localised muscle invasive bladder cancer.
Kouloulias V; Mosa E; Tolia M; Kantzou I; Koliarakis N; Platoni K; Georgakopoulos I; Siatelis A; Sarris G; Beli I; Chrisofos M; Kelekis N
J BUON; 2013; 18(4):942-8. PubMed ID: 24344021
[TBL] [Abstract][Full Text] [Related]
11. Treatment results of radiation therapy for muscle-invasive bladder cancer.
Langsenlehner T; Döller C; Quehenberger F; Stranzl-Lawatsch H; Langsenlehner U; Pummer K; Kapp KS
Strahlenther Onkol; 2010 Apr; 186(4):203-9. PubMed ID: 20354664
[TBL] [Abstract][Full Text] [Related]
12. Influence of the technique and comorbidities in hypofractionated radiotherapy for prostate cancer.
Correa R; Navarro I; Lobato M; Otero A; Jerez I; Rico JM; Zapata I; Lupiañez Y; Medina JA; Olmos D; Gómez-Millán J
Clin Transl Oncol; 2020 Mar; 22(3):311-318. PubMed ID: 31721011
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Hypofractionated Radiotherapy With Capecitabine in Elderly Patients With Urothelial Carcinoma.
Leng J; Akthar AS; Szmulewitz RZ; O'Donnell PH; Sweis RF; Pitroda SP; Smith N; Steinberg GD; Liauw SL
Clin Genitourin Cancer; 2019 Feb; 17(1):e12-e18. PubMed ID: 30392939
[TBL] [Abstract][Full Text] [Related]
14. Could Concurrent Capecitabine with Hypofractionated Radiotherapy in Elderly Patients with Muscle-Invasive Bladder Cancer be an Option?
Youssief AA; Gamal DA; El-Naggar MS; Zarzor MA; A R; Ahmed S
Asian Pac J Cancer Prev; 2022 May; 23(5):1733-1740. PubMed ID: 35633559
[TBL] [Abstract][Full Text] [Related]
15. A comparison of morbidity following conformal versus intensity-modulated radiotherapy for urinary bladder cancer.
Søndergaard J; Holmberg M; Jakobsen AR; Agerbæk M; Muren LP; Høyer M
Acta Oncol; 2014 Oct; 53(10):1321-8. PubMed ID: 24980045
[TBL] [Abstract][Full Text] [Related]
16. Clinical results of conformal versus intensity-modulated radiotherapy using a focal simultaneous boost for muscle-invasive bladder cancer in elderly or medically unfit patients.
Lutkenhaus LJ; van Os RM; Bel A; Hulshof MC
Radiat Oncol; 2016 Mar; 11():45. PubMed ID: 26993980
[TBL] [Abstract][Full Text] [Related]
17. Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer.
Chen WC; Liaw CC; Chuang CK; Chen MF; Chen CS; Lin PY; Chang PL; Chu SH; Wu CT; Hong JH
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):726-33. PubMed ID: 12788178
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy.
Cowan RA; McBain CA; Ryder WD; Wylie JP; Logue JP; Turner SL; Van der Voet J; Collins CD; Khoo VS; Read GR
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):197-207. PubMed ID: 15093917
[TBL] [Abstract][Full Text] [Related]
19. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
[TBL] [Abstract][Full Text] [Related]
20. Optimal management of recurrent and metastatic upper tract urothelial carcinoma: Implications of intensity modulated radiation therapy.
Kim MS; Koom WS; Cho JH; Kim SY; Lee IJ
Radiat Oncol; 2022 Mar; 17(1):51. PubMed ID: 35264197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
